Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 3, 2013, Pages 403-409

  Toumi, Ryma ^a   Abdelouhab, Katia ^a   Rafa, Hayet ^a   Soufli, Imene ^a   Raissi Kerboua, Djamila ^b   Djeraba, Zineb ^a   Touil Boukoffa, Chafia ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Clininical Pathology Laboratory   (Algeria)

Author keywords

Gut microflora; Mucus; Nitric oxide; Peritoneal macrophages; Ulcerative colitis

Indexed keywords

DOCUSATE SODIUM; PROBIOTIC AGENT; ULTRABIOTIQUE; UNCLASSIFIED DRUG;

ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; COLITIS; CONTROLLED STUDY; DRUG FORMULATION; DRUG MIXTURE; EXPERIMENTAL COLITIS; IMMUNE SYSTEM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TISSUE REPAIR;

ANIMALS; BIFIDOBACTERIUM; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; GOBLET CELLS; INTESTINAL MUCOSA; LACTOBACILLUS; MACROPHAGES; MALE; MICE; MUCUS; NITRIC OXIDE; PROBIOTICS;

EID: 84877841696     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.790413     Document Type: Article

References (41)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-443
2. Calop J, Limat S, Fernandez C. Pharmacie clinique et therapeutique. Ed.3, Elsevier Masson 2008;(3):248-268
3. Van Deventer SJ. Tumour necrosis factor and Crohns disease. Gut 1997;40:443-448
4. Abraham C, Ruslan M. Interactions between the host innate immune system and microbes in Inflammatory Bowel Disease. Gastroenterology 2011;140:1729-1737
5. Bing X, Crusius J, Meuwissen S, Pen?a A. Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. WJG 1998;4:446-458
6. Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohns disease. Gut 1995;36:718-723
7. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004;113:427-437
8. Rafa H, Amri M, Saoula H, et al. Involvement of interferon-g in bowel disease pathogenesis by nitric oxide pathway: a study in Algerian patients. J Interferon Cytokine Res 2010;30:691-697
9. Hokari R, Kato S, Matsuzaki K, et al. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 2001;31:153-163
10. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-594
11. Sekirov I, Russell SL, Antunes CM, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904
12. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gutmicrobiota: friends or foes? Nat Rev Immunol 2010;10: 735-744
13. Renes IB, Verburg M, Van Nispen DJ, et al. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int J Colorectal Dis 2002;17:317-326
14. Hans W, Scholmerich J, Gross V, Falk W. The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol 2000;12:267-273
15. Food and Agriculture Organization of the United Nations and World Health Organization (FAO/WHO). Guidelines for the evaluation of probiotics in food; 2002
16. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008;14:1585-1596
17. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004;53:108-114
18. Osman N, Adawi D, Ahrne S, et al. Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig Dis Sci 2004;49:320-327
19. Abdelouhab K, Rafa H, Toumi R, et al. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: effect of probiotics and prebiotics. Immunopharmacol Immunotoxicol 2012;34:590-597
20. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterol 1990;98:694-702
21. Touil-Boukoffa C, Bauvois B, Sanceau J, et al. Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-g levels. Biochimie 1998;80:739-744
22. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10- deficient mice. Inflamm Bowel Dis 2002;8: 71-80
23. McCarthy J, OMahony L, OCallaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-980
24. Wu X, Vallance BA, Boyer L, et al. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 2008;294:G295-G306
25. Kleerebezem M, Vaughan EE. Probiotic and Gut Lactobacilli and Bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 2009;63:269-290
26. Dieleman LA, Ridwan BU, Tennyson GS, et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroentero 1994;107:1643-1652
27. Kumar KG, Dhamotharan R, Kulkarni N, et al. Embelin ameliorates dextran sodium sulfate-induced colitis in mice. Int Immunopharmacol 2011;11:724-773
28. Southey A, Tanaka S, Murakami T, et al. Pathophysiological role of nitric oxide in rat experimental colitis. Int J Immunopharmacol 1997;19:669-676
29. McCafferty DM, Miampamba M, Sihota E, et al. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999;45:864-873
30. Hibbs JBJ, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1998;157:87-94
31. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF"KB/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-4708
32. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Current Drug Targets - Inflammation & Allergy 2005;4:471-479
33. Petrof E, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-iB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004;127: 1474-1487
34. Perdigon G, Galdeano M.C., Valdez JC, Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002;56:S21-S26
35. Macpherson AJ, Harri NL. Interactions between commensal intestinal bacteria and the immune system. Nature Rev Immunol 2004;4:478-485
36. Renes IB, Boshuizen JA, Van Nispen DJ, et al. Alterations in Muc2 biosynthesis and secretion during dextran sulfate sodium-induced colitis. Am J Physiol Gastrointest Liver Physiol 2002;282:382-389
37. Faure M, Moennoz D, Montigon F, et al. Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 2003;48:1366-1373
38. Tytgat K, Van der Wal J, Einerhand A, et al. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 1996;224:397-405
39. Van Der Sluis M, De Koning BA, De Bruijn AC, et al. Muc2- deficient mice spontaneously develop colitis, indicating that Muc2 is critical for colonic protection. Gastroenterology 2006;131: 117-129
40. Mack DR, Ahrne S, Hyde L, et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003;52:827-833
41. Caballero-Franco C, Keller K, De Simone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G315-G322